Screening of Oral Probiotic Lactic Acid Bacteria against Dental Caries

The purpose of this study is to select lactic acid bacteria with a strong ability to inhibit oral pathogens, high safety and strong oral colonization capacity. Firstly, the strains that could inhibit Streptococcus mutans and Streptococcus gordonii were screened from lactic acid bacteria resource bank in the laboratory by Oxford cup diffusion method. The 28 selected strains were evaluated for hemolytic activity. The results showed that seven of the 28 strains showed α-hemolysis while the remaining 21 did not. The antibacterial metabolites of 16 strains without hemolysis and with a diameter of inhibition zone ≥ 10 mm against S. mutans and S. gordonii were determined by neutralization, catalase and protease susceptibility assays. Then seven strains with strong bacteriostatic capacity and the potential to produce non-organic acid antimicrobial metabolites were selected. The safety evaluation results showed that all seven strains had low acid production ability and caused low corrosion to teeth. The highest tolerable concentration of lysozyme for strain JZ14-1 was 1.6 mg/mL, while that for the other six strains was 1.2 mg/mL, indicating that all seven strains could tolerate lysozyme. Strain HB13-2 was most susceptible to antibiotics. The oral colonization capacity evaluation of strain HB13-2 showed the following results: the highest hydrophobicity of 44.00%, surface acid charge of 20.16%, surface base charge of 49.44%, and content of exopolysaccharides of 0.283 mg/mL. This strain could easily colonize in oral cavity and had low biofilm formation capacity and good self-aggregation capacity, and the maximum inhibition percentage against S. mutans biofilm was 59.72%. Moreover, strain HB13-2 had strong copolymerization capacity with S. mutans, and the copolymerization capacity was 67.40% at 24 h. In conclusion, strain HB13-2 has good antibacterial activity, high safety and strong oral colonization capacity. It is identified as Lactiplantibacillus plantarum by 16S rDNA sequencing.